LLY Earnings

LLY reported its earnings on 2026-02-04, showcasing a revenue of 19.29B against an estimate of 17.87B, resulting in a 7.96% surprise. The EPS was 7.54, surpassing the expected 6.99 by 7.87%. The stock experienced a 10.33% price change on the earnings day and a 4.11% change over the next five days, reflecting market reactions to the results.

Following LLY's earnings announcement on 2026-02-04, the stock price moved by 10.33% on the day of the release. Over the subsequent five days, it saw a 4.11% change. Historically, LLY's stock price tends to shift by an average of -0.72% in the 10 days leading up to earnings and 3.08% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate LLY's annual revenue to reach 17.01B, while the EPS is projected at 7.46. These estimates reflect recent revisions, with revenue estimates revised upward by 0.07% and EPS estimates revised upward by 0.24% over the past three months, indicating analyst expectation in the company's performance.

The correlation between LLY's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were revised upward by 0.07%, while EPS estimates moved revised upward by 0.24%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, LLY's stock price typically moves by -0.72% in the 10 days before its earnings and 3.08% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 7.46 and revenue of 17.01B.

The earnings call summary reflects strong financial performance, with significant revenue and EPS growth, increased guidance, and positive market trends. Product development updates, especially for orforglipron, indicate potential future growth. The Q&A section reveals optimism about new product launches and market expansion, despite some unanswered questions about cash pay dynamics. The company's strategic reinvestments and shareholder returns further support a positive outlook, although the lack of specific guidance metrics and management's evasive responses slightly temper the sentiment.